文献速递免疫规划卫生政策与健康促进

2017与2018年出生儿童24月龄疫苗接种覆盖率:美国国家免疫调查-儿童(2018-2020)

Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-10-15

CDC利用国家免疫调查-儿童(NIS-Child)数据,评估2017与2018年出生儿童在24月龄时接种ACIP推荐疫苗的覆盖率,并与2015与2016年出生儿童比较。全国层面,脊灰疫苗≥3剂覆盖率最高(92.7%),流感疫苗≥2剂最低(60.6%);轮状病毒疫苗、甲肝疫苗≥1剂、乙肝疫苗出生剂次和流感疫苗≥2剂覆盖率较2015-2016年出生儿童提高2.1-4.5个百分点。仅1.0%儿童在24月龄时未接种任何疫苗;种族/民族、贫困状况和保险状态存在覆盖率差异,未参保儿童差异最大。

要点

  • 2017-2018年出生儿童24月龄时,脊灰疫苗≥3剂覆盖率92.7%,流感疫苗≥2剂仅60.6%。
  • 轮状病毒疫苗、甲肝疫苗≥1剂、乙肝疫苗出生剂次和流感疫苗≥2剂覆盖率较2015-2016年出生儿童提高2.1-4.5个百分点。
  • 仅1.0%儿童24月龄时未接种任何疫苗;未参保儿童在流感疫苗、7疫苗联合系列和轮状病毒疫苗上差异最大。

核心结论

  • 2017-2018年出生儿童24月龄时多数ACIP推荐疫苗覆盖率较高,但流感疫苗≥2剂覆盖率最低(60.6%)。
  • 部分疫苗覆盖率较2015-2016年出生儿童提高2.1-4.5个百分点,但种族/民族、贫困和保险状态差异持续存在。
  • 需额外努力确保漏种儿童(包括因COVID-19大流行所致)尽快补种。

研究设计与样本

  • CDC利用国家免疫调查-儿童(NIS-Child)数据,评估2017与2018年出生儿童24月龄疫苗接种覆盖率,并与2015与2016年出生儿童比较。
  • 覆盖全国、地区、州、领地和部分地方层面ACIP推荐疫苗的常规接种覆盖率。

主要发现

  • 全国覆盖率最高为脊灰疫苗≥3剂(92.7%)、乙肝疫苗≥3剂(91.9%)、麻腮风疫苗≥1剂(91.6%)和水痘疫苗≥1剂(90.9%)。
  • 覆盖率最低为流感疫苗≥2剂(60.6%)。
  • 2017-2018年出生儿童轮状病毒疫苗、甲肝疫苗≥1剂、乙肝疫苗出生剂次和流感疫苗≥2剂覆盖率较2015-2016年出生儿童高2.1-4.5个百分点。
  • 仅1.0%儿童在24月龄时未接种任何疫苗。
  • 种族/民族、贫困状况和保险状态存在覆盖率差异;未参保儿童在流感疫苗≥2剂、7疫苗联合系列和轮状病毒疫苗上差异最大。

关键数值与推荐

  • ACIP建议儿童在出生后24个月内接种针对14种疾病的疫苗。
  • 全国覆盖率:脊灰疫苗≥3剂92.7%;乙肝疫苗≥3剂91.9%;麻腮风疫苗≥1剂91.6%;水痘疫苗≥1剂90.9%;流感疫苗≥2剂60.6%。
  • 2017-2018年出生儿童较2015-2016年出生儿童覆盖率提高2.1-4.5个百分点(轮状病毒疫苗、甲肝疫苗≥1剂、乙肝疫苗出生剂次、流感疫苗≥2剂)。
  • 仅1.0%儿童24月龄时未接种任何疫苗。

临床怎么用

  • 利用NIS-Child监测数据识别覆盖率较低疫苗(如流感疫苗≥2剂)和差异较大人群(如未参保儿童),针对性加强接种。
  • 对漏种儿童(包括因COVID-19大流行所致)尽快补种,以维持对疫苗可预防疾病的保护。

局限性

  • 报告估计反映的接种机会主要发生在COVID-19大流行导致中断之前。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunization is a safe and cost-effective means of preventing illness in young children and interrupting disease transmission within the community.* The Advisory Committee on Immunization Practices (ACIP) recommends vaccination of children against 14 diseases during the first 24 months of life (1). CDC uses National Immunization Survey-Child (NIS-Child) data to monitor routine coverage with ACIP-recommended vaccines in the United States at the national, regional, state, territorial, and selected local levels.† CDC assessed vaccination coverage by age 24 months among children born in 2017 and 2018, with comparisons to children born in 2015 and 2016. Nationally, coverage was highest for ≥3 doses of poliovirus vaccine (92.7%); ≥3 doses of hepatitis B vaccine (HepB) (91.9%); ≥1 dose of measles, mumps, and rubella vaccine (MMR) (91.6%); and ≥1 dose of varicella vaccine (VAR) (90.9%). Coverage was lowest for ≥2 doses of influenza vaccine (60.6%). Coverage among children born in 2017-2018 was 2.1-4.5 percentage points higher than it was among those born in 2015-2016 for rotavirus vaccine, ≥1 dose of hepatitis A vaccine (HepA), the HepB birth dose, and ≥2 doses of influenza vaccine. Only 1.0% of children had received no vaccinations by age 24 months. Disparities in coverage were seen for race/ethnicity, poverty status, and health insurance status. Coverage with most vaccines was lower among children who were not privately insured. The largest disparities between insurance categories were among uninsured children, especially for ≥2 doses of influenza vaccine, the combined 7-vaccine series, § and rotavirus vaccination. Reported estimates reflect vaccination opportunities that mostly occurred before disruptions resulting from the COVID-19 pandemic. Extra efforts are needed to ensure that children who missed vaccinations, including those attributable to the COVID-19 pandemic, receive them as soon as possible to maintain protection against vaccine-preventable illnesses.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Hill HA, Yankey D, Elam-Evans LD, et al. Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34648486. doi:10.15585/mmwr.mm7041a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。